Showing results (111-120 of 199) with videos related to
Sort By:
Pageof 20
The Prostate|January 1, 1987
Enhanced expression of the c-myc protooncogene in high-grade human prostate cancersR Buttyan, I S Sawczuk, M C Benson, et al.Kidney International|June 1, 1991
SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosisJ Connor, R Buttyan, C A Olsson, et al.The Prostate|May 8, 2000
Galactosyl receptor, a cell surface C-type lectin of normal and tumoral prostate epithelial cells with binding affinity to endothelial cellsA L Kierszenbaum, E Rivkin, P L Chang, et al.Urologic Oncology|January 14, 2011
Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted mediumR Shen, T Dorai, M Szaboles, et al.The Journal of Urology|August 1, 1992
The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladderJ G Giella, K Ring, C A Olsson, et al.Journal of the National Cancer Institute|January 19, 1994
Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surfaceR Shen, Z Z Su, C A Olsson, et al.Urology|April 1, 1982
Adjunctive therapy with interstitial irradiation for prostate cancerR deVere White, R K Babaian, M Feldman, et al.The Journal of Urology|February 1, 1990
Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injuryM G Bandyk, I S Sawczuk, C A Olsson, et al.The Journal of Urology|February 1, 1984
Misonidazole as a chemosensitizer in the treatment of the Dunning prostate cancer modelR D White, N A Romas, P Tomashefsky, et al.Urology|December 1, 1989
Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concernJ P Connor, C A Olsson, M C Benson, et al.Pageof 20